Imperial College London: Cardiovascular Diseases trials

The registry lists 15 Cardiovascular Diseases studies with Imperial College London as lead sponsor. 4 are open to participants now and 3 have results posted.

Phase 3 2Phase 4 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pulmonary Arterial Hypertension and Associated Cardiovascular Disease Detection Using Artificial IntelligenceNot yet recruitingNCT07147725
• Artificial Intelligence Delivered Cardiac Magnetic Resonance - Prospective ValidationRecruitingNCT06061822Not applicable
• Smart Wearable Insights to Prevent Exacerbations and Recurrence - Rehabilitation Study: SWIPER-REHABNot yet recruitingNCT06011395
• Inherited Cardiac cONditions In KidsRecruitingNCT05158738
• Telemedicine in High-Risk Cardiovascular Patients Post-ACSCompletedNCT05015634Not applicableResults posted
• Self-Assessment Method for Statin Side-effects Or NoceboCompletedNCT02668016Phase 4Results posted
• Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up StudyCompletedNCT01499511Results posted
• Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement StudyActive, not recruitingNCT06011356
• Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled StethoscopeActive, not recruitingNCT05987670Not applicable
• Defining the Genetics, Biomarkers and Outcomes for Dilated CardiomyopathyActive, not recruitingNCT03843255
• EUROASPIRE V Survey on Cardiovascular Disease Prevention and DiabetesCompletedNCT03511885
• An Observational Study of Natural History of Cardiovascular DiseasesCompletedNCT02077023
• Yoga And Cardiovascular Health TrialCompletedNCT01597960Not applicable
• Polypill Effects on Sub Clinical Atherosclerosis (PESCA) TrialWithdrawnNCT01326676Phase 3
• UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular EventsCompletedNCT01057537Phase 3